- socially bharat
- September 24, 2024
Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea
TOKYO, Japan & Seattle, Cambridge, Mass., United States: World’s first approved allogeneic cell therapy for corneal endothelial disease Prof. Shigeru